- Clovis Oncology announces second US patent issued in Rucaparib high dosage strength tablet Seeking Alpha
- Clovis Oncology Announces Second US Patent Issued in Rucaparib High Dosage Strength Tablet Patent Family with … Business Wire (press release)
- Clovis Oncology (CLVS) Announces Second US Patent Issued in Rucaparib High Dosage Strength Tablet Patent Family StreetInsider.com
Full coverage
|
